SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-24-033802
Filing Date
2024-02-13
Accepted
2024-02-13 16:30:50
Documents
2
Group Members
JAMES HUANGPANACEA VENTURE HEALTHCARE FUND II GP COMPANY, LTD.PANACEA VENTURE HEALTHCARE FUND II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D d785507dsc13d.htm SC 13D 105206
2 EX-99.1 d785507dex991.htm EX-99.1 5939
  Complete submission text file 0001193125-24-033802.txt   112936
Mailing Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Subject) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92416 | Film No.: 24626580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PANACEA VENTURE, NO. 5, LANE 1350 FUXING MIDDLE ROAD SHANGHAI F4 200031
Business Address C/O PANACEA VENTURE, NO. 5, LANE 1350 FUXING MIDDLE ROAD SHANGHAI F4 200031 86 21 60252100
Panacea Innovation Ltd (Filed by) CIK: 0002010692 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D